A Study of Napabucasin (BBI-608) in Combination With FOLFIRI in Adult Patients With Previously Treated Metastatic Colorectal Cancer

NCT02753127 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1253

Enrollment

INDUSTRY

Sponsor class

Conditions

Colorectal Cancer

Interventions

DRUG: Napabucasin
DRUG: Fluorouracil
DRUG: Leucovorin
DRUG: Irinotecan
DRUG: Bevacizumab

Sponsor

Sumitomo Pharma America, Inc.